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Abstract Mild cognitive impairment (MCI) has been 
described as an intermediate stage between normal ag-
ing and dementia. Previous studies characterized the 
alterations of brain oscillatory activity at this stage, but 
little is known about the differences between single and 
multidomain amnestic MCI patients. In order to study 
the patterns of oscillatory magnetic activity in amnestic 
MCI subtypes, a total of 105 subjects underwent an 
eyes-closed resting-state magnetoencephalographic re-
cording: 36 healthy controls, 33 amnestic single domain 
MCIs (a-sd-MCI), and 36 amnestic multidomain MCIs 
(a-md-MCI). Relative power values were calculated and 
compared among groups. Subsequently, relative power 
values were correlated with neuropsychological tests 
scores and hippocampal volumes. Both MCI groups 
showed an increase in relative power in lower frequency 
bands (delta and theta frequency ranges) and a decrease in 
power values in higher frequency bands (alpha and beta 
frequency ranges), as compared with the control group. 
More importantly, clear differences emerged from the 
comparison between the two amnestic MCI subtypes. 
The a-md-MCI group showed a significant power in-
crease within delta and theta ranges and reduced relative 
power within alpha and beta ranges. Such pattern corre-
lated with the neuropsychological performance, indicat-
ing that the a-md-MCI subtype is associated not only with 
a "slowing" of the spectrum but also with a poorer 
cognitive status. These results suggest that a-md-MCI 
patients are characterized by a brain activity profile that 
is closer to that observed in Alzheimer disease. Therefore, 
it might be hypothesized that the likelihood of conversion 
to dementia would be higher within this subtype. 
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Introduction 
The definition of mild cognitive impairment (MCI) 
underwent a notable evolution during the last two de-
cades. In essence, the concept of MCI was coined to 
define a clinical condition where an objective cognitive 
decline can be detected, but this dec Une is still not severe 
enough to be considered a full-blown dementia. 
Petersen and the Mayo Clinic group (Petersen et al. 
1999) offered one of the first operational definitions of 
MCI, which was subsequently accepted by a majority of 
the scientific community. In the first characterization of 
Petersen et al. (2001), MCI was a predominantly 
amnestic problem. MCI was also characterized as a 
"transitional state." Thus, this clinical condition would 
be an intermediate state or a "boundary" between nor-
mal aging and dementia, since a number of studies 
demonstrated that patients with a diagnosis of MCI are 
at higher risk of developing Alzheimer's disease (AD) 
when compared with the healthy aged population 
(Farias et al. 2005; Petersen 2005; Shah et al. 2000). 
Following up this evolution, two articles represented 
a key modification of MCI concept (Petersen 2004; 
Winblad et al. 2004). The original notion of a predom-
inant amnestic problem was substituted by a new per-
spective where several clinical subtypes of MCI were 
described. This new perspective classified patients ac-
cording to two orthogonal axes. In the first axis, patients 
with a predominant memory defect are classified as 
"amnestic MCI" (a-MCI), while those with a predomi-
nant impairment in cognitive domains such as language, 
executive functions, or visuospatial skills are classified 
as "nonamnestic MCI" (na-MCI). In the second axis, 
patients are categorized according to the number of 
affected cognitive domains. Those with only one affect-
ed domain (e.g., memory or language) are categorized 
as "single domain" MCIs (sd-MCI), while those with 
more than one affected domain (e.g., memory plus 
language) are categorized as "multidomain" MCIs 
(md-MCI). The combination of these axes gives 
rise to the nowadays more broadly utilized classi-
fication of MCI subtypes: amnestic single domain 
MCI (a-sd-MCI), amnestic multidomain MCI (a-
md-MCI), nonmanestic single domain MCI (na-
sd-MCI), and nonamnestic multidomain MCI (na-
md-MCI). 
This clinical classification is extremely relevant be-
cause each subtype is linked to a presumed etiology. 
According to Petersen's group, the amnestic subtypes 
(including single and multidomain) represent a prodro-
mal form of AD, although vascular dementia may be 
also considered (Petersen 2004). Nonamnestic subtypes 
might be at higher risk of conversion to Lewy-body or 
frontotemporal dementias (Petersen 2004; Winblad 
et al. 2004). Implicitly, this categorization still assumes 
that MCI is a "predementia" stage, and most patients 
would convert to some type of dementia if they are 
followed up for enough time. However, investigations 
such as the population-based PAQUID study (Larrieu 
et al. 2002) demonstrated that this implicit assumption 
was not totally true. On the contrary, MCI emerged as an 
unstable clinical condition, with some patients 
progressing to different dementias, some patients re-
maining clinically stable over time, and notably some 
patients reverting to a "normal" clinical situation (40 % 
in the PAQUID study for example). As a consequence 
of this new scenario, recent proposals of MCI diagnostic 
criteria (Albert et al. 2011) claim the utilization of a very 
strict terminology (i.e., "MCI due to AD"), since differ-
ent etiologies that yield different outcomes (including 
the reversion to a "normal" condition) might be under-
lying the observed cognitive deterioration. 
Despite of the new consideration of MCI as an un-
stable condition, there is still solid evidence supporting 
the higher risk of conversion to dementia (especially 
AD) in this group of patients (Bennett et al. 2005; 
Gauthier et al. 2006; Morris et al. 2001). Therefore, 
the early detection of MCI is still a critical issue regard-
ing the development of interventions to prevent or delay 
the process of neurodegeneration (Jelic et al. 2005). In 
order to attain such goal, it is important to bear in mind 
that clinical subtypes of MCI are not only associated 
with different etiologies but also with a more or less 
rapid conversion to dementia (Brodaty et al. 2012; 
Tabert et al. 2006). Considering this fact, a great effort 
has been devoted to investigate biological markers that 
may characterize the clinical subtypes of MCI. 
Neurophysiological techniques such as electroen-
cephalography (EEG) or magneto encephalography 
(MEG) played a significant role in this line of research. 
The most stable partem of EEG activity in MCI patients 
is defined by an increase in theta accompanied by a 
decrease of alpha and beta power, which correlates with 
APOE genotype, and hippocampal volumes (Babiloni 
et al. 2006b, c, 2009; Grunwald et al. 2002; Prichep 
et al. 2006). When the progression to AD was investi-
gated, alpha and theta relative power in left temporo-
occipital derivation correctly classified 85 % of MCI 
subjects who would suffer dementia (Jelic et al. 2000). 
Huang et al. (2000) demonstrated that a more anterior 
localization of theta and alpha activity was the best 
predictor of future conversion to AD within a MCI 
sample. Of note, the investigation of differential neuro-
physiological patterns in MCI subtypes is scarce. This 
issue was indirectly addressed by Babiloni et al. (2009) 
within the background of a research on the relationship 
between hippocampal volumes and alpha rhythms. The 
authors assessed a potential influence of the clinical 
subtype (i.e., a-MCI vs. na-MCI) and found no signifi-
cant differences. In a subsequent study (Babiloni et al. 
2010), the issue was explicitly investigated by compar-
ing EEG rhythms in a-MCIs, na-MCIs, and aged sub-
jects with subjective memory complaints. Results 
showed increased occipital theta and reduced alpha 
activity in a-MCI, as compared to na-MCI. No distinc-
tions were made in terms a single or multidomain 
affectation. 
Considering the scarcity of studies within this field 
and its potential clinical relevance, we conducted a 
MEG study where an exhaustive spectral analysis was 
carried out in a-sd-MCIs, a-md-MCIs, and healthy aged 
controls. Recently, a-md-MCI has been associated with 
increased levels of AD pathology and elevated risk of 
conversion to AD when compared with a-sd-MCI 
(Zhang et al. 2012; Brodaty et al. 2012; Wolk et al. 
2009). As a consequence, we not only expect the typical 
pattern of increased theta and reduced alpha in the MCI 
groups. Furthermore, we hypothesize that a-md-MCI 
patients will exhibit a spectral partem more proximate 
to the typical AD profile, including increased power 
within the delta and theta frequency ranges, and reduced 
activity in the high-frequency range as compared with a-
sd-MCIs and healthy controls. Finally, bearing in mind 
that mesial-temporal atrophy is one of the more impor-
tant markers within the normal aging-AD spectrum (see, 
for example, Jack et al. 1999; Martin et al. 2010), 
hippocampal volumes were calculated in order to assess 
the relationship between structural and functional infor-
mation. To the best of our knowledge, this is the first 
neurophysiological study that combines spectral activi-
ty, neuropsychological performance, and hippocampal 
atrophy information to characterize the two amnesic 
clinical subtypes of MCI. 
Methods 
Subjects 
MEG signals were obtained from 105 subjects older 
than 65 years of age, classified in three groups: 36 
healthy controls, 33 a-sd-MCI patients, and 36 a-md-
MCI patients. All of them were right-handed (Oldfield 
1971) and native Spanish speakers. No significant dif-
ferences were found in education, gender, or age among 
groups (see Table 1). MCI patients were recruited from 
the Geriatrics and Neurology Units of the "Hospital 
Universitario San Carlos" and the "Memory Decline 
Prevention Center," both in Madrid, Spain. Healthy 
volunteers were recruited from the "Seniors Center of 
Chamartin District," Madrid. 
Diagnostic criteria 
All participants were screened by means of a variety of 
standardized diagnostic instruments that included: the 
Spanish version of the Mini Mental State Examination 
(MMSE; Lobo et al. 1979), the Global Deterioration 
Scale (GDS; Reisberg et al. 1982), the Functional as-
sessment questionnaire (FAQ; Pfeffer et al. 1982), the 
Tkble 1 Mean values (istandard deviation) of the demographic and clinical characteristics of a-sd-MCI, a-md-MCI, and controls 
Age (years) 
Gender (M/F) 
MMSE score 
Education (years) 
LHJCV 
RHJCV 
Control («=36) 
72.36±4.75 
11/25 
29.14±0.96 
4.39±1.23 
0.002610±0.0003583 
0.002608±0.0002964 
a-sd-MCI (n-
74.15±6.07 
13/20 
27.63±2.47 
4.27Ü.31 
=33) 
0.002148±0.0004235 
0.002133 ±0.0005079 
a-md-MCI (n-
73.94±3.70 
13/23 
25.65±2.66 
3.78±1.24 
=36) 
0.002062±0.0005280 
0.002082±0.0003512 
p value 
p=0.22 
p=0.12 
p<0.01 
p=0.48 
/XO.0001 
/XO.0001 
An ANOVA test was used for the comparisons 
Mmale, F female, MMSE Mini-mental state examination score 
Geriatric Depression Scale (GDS; Yesavage et al. 1982), 
the Hachinski Ischemic Score (Rosen et al. 1980), the 
questionnaire for Instrumental Activities of Daily 
Living (Lawton and Brodie 1969), and the Functional 
Assessment Staging (FAST; Auer and Reisberg 1997). 
MCI diagnosis was established according to the 
criteria of Petersen (2004) and Grundman et al. (2004). 
Thus, MCI patients should fulfill the following require-
ments: (1) memory complaint, corroborated by an infor-
mant; (2) abnormal memory function, documented by 
delayed recall of one paragraph from the Logical Mem-
ory II subtest of the Wechsler Memory Scale—Revised 
(cutoff scores< 16 for >16 years of education; <8 for >8-
15 years of education); (3) normal general cognitive 
function, as determined by a MMSE score >24; (4) total 
absence or minimal impairment in activities of daily 
living revealed by the Lawton scale, as determined by 
a clinical interview with the patient and informant; and 
(5) not demented according to the National Institute of 
Neurological and Communicative Disorders and Stroke/ 
Alzheimer's Disease and Related Disorders Association 
criteria as judged by an experienced clinician (McKhann 
et al. 1984). MCIs did not fulfill the diagnostic criteria 
for dementia (i.e., all were classified at the stage 3 of the 
Global Deterioration Scale) and performed at least 1 SD 
below average for their age and education on neuropsy-
chological tests representing one or more areas of cog-
nition (lelic et al. 1996). Patients and controls were free 
of significant medical, neurological and/or psychiatric 
diseases (other than MCI). These inclusion criteria 
encompassed the absence of significant cerebral-
vascular disease (i.e., modified Hachinski score<4) or 
depressive symptomatology (i.e., Yesavage's 
Depression Scale scores> 9). Participants were not using 
drugs, which could affect MEG activity (including cho-
linesterase inhibitors). 
Patients and controls received an exhaustive neuro-
psychological assessment in order to establish their per-
formance level in multiple cognitive domains. The as-
sessment included clock drawing test (Agrell and 
Dehlin 1998), direct and inverse digit span tests 
(Wechsler Memory Scale Revised, WMS-III; Wechsler 
1987), immediate and delayed recall (WMS-III; 
Wechsler 1987), phonemic and semantic fluency 
(Controlled Oral Word Association Test; Benton and 
Hamsher 1989), ideomotor praxis of Barcelona test 
(Pefia-Casanova 1990), rule shift Cards (BADS; Norris 
and Tate 2000), visual object and space perception test 
(VOSP; Warrington and lames 1991), Boston naming 
test (BNT; Kaplan et al. 1983), and trail making test A 
and B (TMTA and TMTB; Reitan 1958). The TMT 
subtest A and B offer two different scores. The first 
one (i.e., TMT "accuracy") denotes the number of cor-
rect responses. The second score (i.e., TMT "time") 
denotes the time subjects need to complete the task, with 
a limit of 200 s in TMTA and 400 s in TMTB. 
According to their clinical and neuropsychological 
profile, patients were further divided in two groups: (1) 
the a-md-MCI group where patients showed a memory 
deficit accompanied by various degrees of impairment 
in cognitive domains such as language, executive func-
tion, and/or visuospatial skills and (2) the a-sd-MCI 
group where patients exhibited an isolated memory 
impairment (Petersen 2004). 
Prior to the MEG recording, all subjects signed an 
informed consent that explained the technical and ethi-
cal considerations of the investigation. The study was 
approved by the local ethics committee. 
MEG recordings 
MEGs were acquired (Fig. 1, step 1) with a 306-channel 
Vectorview system (ElektaNeuromag), which combines 
two orthogonal, planar gradiometers, and one magne-
tometer. Only MEG signals derived from magnetome-
ters (i.e., 102 channels) were submitted for further anal-
yses. The MEG system was placed in a magnetically 
shielded room (VacuumSchmelze GmbH, Hanua, Ger-
many) at the "Laboratorio UPM-UCM de Neurociencia 
Cognitivay Computational" (Madrid, Spain). Subjects 
were in an awake but resting state with their eyes closed 
and under vigilance control during the recording. They 
were asked to avoid making movements. For each sub-
ject, 3 min of MEG signal were acquired at a sampling 
frequency of 1,000 Hz (online bandpass filtering at 0.1-
330 Hz). 
The head movement was controlled by means of a 
head-position indicator (HPI) with coils attached to the 
scalp. HPI coils position and subject head shape were 
defined using a three-dimensional digitizer 
(FastrakPolhemus) referenced to three anatomical 
(fiducial) locations: the nasion and the left and right 
preauricular points. Bunks were monitored by two bi-
polar electrodes attached above and below the left eye 
and one electro attached to the lower cheek (ground). 
Recordings were offline filtered (Fig. 1, step 2) and 
corrected for head movements with a temporal signal 
space separation with movement compensation (Tsss-
mc) (Taulu and Kajola 2005, Maxfilter 2.2 software); 
correlation threshold=0.9, time window=10 s, and 
notch filtered (Butterworth filter order 4 at 50 Hz and 
100 Hz). Continuously recorded resting state data were 
segmented in 4-s length trials. Trials with electroocu-
lography, muscle, and jump artifacts were rejected by 
means of Fieldtrip package (Oostenveld et al. 2011) 
(Fig. 1, step 3). 
MRI and hippocampal volumes 
For each subject, a high-resolution Tl-weighted mag-
netic resonance was acquired at "Hospital Universitario 
San Carlos" (Madrid) using a General Electric 1.5-T 
magnetic resonance scanner, with a high-resolution an-
tenna and a homogenization PURE filter (fast spoiled 
gradient echo sequence, TR/TE/TI=11.2/4.2/450 ms; 
flip angle, 12°; 1 mm slice thickness, 256x256 matrix; 
and FOV, 25 cm). To segment the subject's Tl-
weighted volume into different regions, Freesurfer soft-
ware (version 5.1.0) and its specialized tool for auto-
mated subcortical segmentation (Fischl et al. 2002) 
were used. Afterwards, hippocampal volumes were 
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Fig. 1 Workflow: resting state MEG recordings (7), Elekta software spatial filtering (2), signal segmentation (3), Fieldtrip artifact 
processing (4), visual trial selection through power spectra (5), power spectra averaging and normalization (6), statistics (7), and results (8) 
normalized with the overall intracranial volume (ICV) 
to account for differences in head volume over subjects. 
Two variables were submitted for statistical analysis: the 
normalized left hippocampal volumes (LHICV) and 
the normalized right hippocampal volumes (RHICV). 
Power spectra and statistical analysis 
MEG power spectra were computed through Fieldtrip 
package for all trials, which successfully passed the 
automatic artifact rejection. A frequency-of-interest 
range of 0.5 Hz steps from 1 to 30 Hz was employed. 
In order to obtain the average frequency content of each 
trial, we applied a multitaper method (mtmfft) with 
discrete prolate spheroidal sequences (dpss) as 
windowing function and 1 Hz smoothing. Each trial 
was visually inspected by an experienced technician 
blinded to the subjects' diagnosis by collapsing the 
power spectrum of all channels (Fig. 1, step 4). Those 
channels with an aberrant power spectra profile were 
dismissed. Finally, only MEG recordings with at least 
15 survival trials (1 min of brain activity) were submit-
ted for further analyses. The number of survival trials 
did not differ significantly among groups. Survival trials 
were averaged across subjects obtaining for each group 
a 102 channels><52 frequency stepsx'V subjects ma-
trix (Fig. 1, step 6). For each channel, relative power 
was calculated as a ratio between power in each 0.5 Hz 
frequency step and the total power across the l-30Hz 
spectrum and was expressed as a percentage (Jelic et al. 
2000). 
Similarly to previous works (see Fernandez et al. 
2006a), we did not use pre-established and conventional 
frequency bands to analyze power differences among 
groups. This approach might overcome one of the key 
problems that emerge when different studies are to be 
compared: the variability in terms of classification 
criteria for classical EEG bands. This variability affects 
low frequencies to a lesser extent; however, the limits 
between conventional bands in the high-frequency 
range are difficult to define. Thereby, in order to accom-
plish a data-driven comparison among groups, we 
followed a method adapted from Maris and Oostenveld 
(2007). First, a series of exploratory ANOVA tests were 
calculated (Fig. 1, step 7) for relative power values in 
each 0.5-Hz frequency step and sensor. Those compar-
isons that were found to show significant differences 
(p<0.05) were further inspected by means of pairwise t 
tests. In order to perform such analyses, a series of 
clusters were built according to a criteria of spatial and 
frequency adjacency. Thus, each cluster must contain at 
least five contiguous and significant sensors, and the 
difference between pairs of groups must remain signif-
icant during at least a 2-Hz interval. 
Relative power on each cluster of sensors was aver-
aged and submitted to the t test analyses. To control the 
family-wise error due to multiple comparisons, the test 
distribution was derived from a permutation test (Ernst 
2004). This was accomplished by randomly dividing the 
participants into two sets, matching the numbers in the 
original groups. The two-sample t test was then carried 
out in these two new groups. This procedure was re-
peated 5,000 times, and thep value from each test was 
retained in order to obtain a p value distribution. We 
then identified the fifth percentile of each distribution, 
and only/» values below that threshold were accepted. 
This strategy was performed for the contrasts a-sd-MCI 
vs. control, a-md-MCI vs. control, and a-sd-MCI vs. a-
md-MCI. Importantly, the criteria utilized to build each 
cluster (see above) determines the way in which spectral 
differences between groups will be described in the 
results section. As above mentioned, results will not be 
described in terms of conventional frequency bands, but 
rather in terms of the frequency ranges of those signif-
icant clusters that matched the adopted criteria of spatial 
and frequency adjacency. 
Power, hippocampal volumes, and neuropsychology 
correlation 
First, a series of one-way ANOVA tests were performed 
in order to investigate the distribution of the neuropsy-
chological scores and the hippocampal volumes among 
groups. In these analyses, the variable "Diagnosis" (a-
md-MCI, a-sd-MCI, control) was considered the be-
tween groups factor. Then, the relationship among pow-
er values, hippocampal volumes, and neuropsychologi-
cal performance was assessed through Pearson correla-
tion tests. The analyses were performed by correlating 
the averaged power on each resulting significant cluster 
of sensors in the t test analyses (see below), and the 
neuropsychological scores on each test. In order to avoid 
the multiple comparisons problem, a permutation testing 
procedure was used (Nichols and Holmes 2001). Five 
thousand surrogate correlation maps were calculated by 
randomly distributing the combination of each power 
value and test score across subjects. The highest abso-
lute value of the Pearson correlation coefficient obtained 
from each surrogate was retained in order to obtain an 
empirical null distribution of the statistic. Statistically 
significant thresholds were obtained from the quantiles 
of the distribution of these values. For example, the 95th 
quantile corresponded to ap value of 0.05. This ensures 
that there is only a 5 % probability that one or more 
correlation values from the original statistical map 
would present differences above threshold due to spuri-
ous statistical fluctuations. 
Results 
Description of power spectra 
First, only for descriptive purposes, we calculated the 
averaged relative power in the 1-30 Hz frequency range 
for each group (see Fig. 2). It can be noticed that a power 
shift to lower frequencies was observed in MCIs, espe-
cially in a-md-MCI patients. Thus, the averaged relative 
power in a-md-MCI patients showed a frequency peak 
of about 8.5 Hz, while in a-sd-MCI subjects, the peak 
appeared at about 9.5 Hz. Healthy controls showed their 
maximum value at about 10 Hz. Moreover, the profile of 
the spectral distribution was quite different among 
groups. Both MCI groups (especially the a-md-MCI 
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Fig. 2 Average relative power spectra for all channels in the 
control group (green line), the a-sd-MCI group {blue dashed line), 
and the a-md-MCI group {red dotted line). Spectra are represented 
in the "x" axis from 1 to 30 Hz frequency band and relative power 
group) showed a broader spectral distribution in the 5-
12 Hz frequency range, indicating a higher variability 
and a tendency to lower frequency peaks across sub-
jects. On the contrary, the control group exhibited a 
narrower spectral distribution, indicating a lower vari-
ability and a tendency to frequency peaks that converge 
within the range of alpha band. 
Differences in relative power among groups 
As previously mentioned, a series of exploratory 
ANOVA tests were calculated for each 0.5 Hz frequency 
step and sensor. The results of those ANOVAs are 
displayed in Fig. 3. Overall, significant differences seem 
to converge within three frequency ranges: (1) a low-
frequency range that includes frequencies between 2 
and 8 Hz, (2) a range that includes frequencies between 
9 and 12 Hz, and (3) a high-frequency range that in-
cludes frequencies between 16 and 23 Hz. These pre-
liminary results might give us a hint about the frequency 
distribution of the significant clusters in the pairwise 
comparison. 
In order to compare our results with previous MEG 
and EEG literature, significant clusters were referred in 
the range of the classical frequency bands (delta, 
theta...). 
values in the "y" axis. It is very important to point out for the reader 
that, in all figures, the red color represents the a-md-MCI group, 
the blue color represents the a-sd-MCI group and the green color 
represents the control group 
0.08 
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Fig. 3 Significant F values corresponding to the exploratory ANOVA tests for each sensor and frequency step (left side). MEG helmet 
layout showing the distribution of sensors (right side) 
Differences within the delta band range 
The a-md-MCI group showed a significant increase in 
activity within the delta range as compared with a-sd-
MCIs and healthy controls (see Fig. 4). Differences 
between a-md-MCIs and a-sd-MCIs (£=-3.331; 
/?<0.001) appeared within a frequency range of 2-
4 Hz in a cluster of sensors located in left centro-
parietal regions (henceforth called cluster S{). The sig-
nificant differences between a-sd-MCIs and controls (t-
-2.280; p<0.05) emerged from cluster of sensors also 
within the 2-A Hz frequency range (cluster <52) located in 
occipital regions. Finally, significant differences be-
tween a-md-MCIs and controls (£=-3.123; ¿><0.001) 
emerged within the same 2-4 Hz frequency range in a 
cluster (<53) with a broader occipito-temporal distribution 
a-sd-MCl vs a-md-MCI Control vs a-sd-MCI Control vs a-md-MCI 
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Fig. 4 Differences within the delta band range. Red color indi-
cates that the a-md-MCI group had more relative power than a-sd-
MCI in left centro-parietal regions (cluster 8{) and in occipito-
| CLUSTER S , 
temporal areas in comparison with the control group (cluster <53). 
Blue color indicates that the a-sd-MCI had more relative power in 
posterior regions than the control group (cluster 82) 
a-sd-MCI vs a-md-MCI Control vs a-sd-MCI Control vs a-md-MCI 
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Fig. 5 Differences within the theta band range. Red color indi-
cates that the a-md-MCI group exhibited more relative power in 
left centro-parietal regions than a-sd-MCI group (cluster 6{) and in 
practically the whole head when compared with control group 
(cluster d4). The a-sd-MCI exhibited a significant power increase 
compared with the control group in two clusters of sensors, repre-
sented in blue color, which involved the right lateral fronto-
temporo-parieto-occipital region (cluster d2) a n d m e left fionto-
central location (cluster d3) 
as compared with cluster S2. Importantly (see below), 
cluster ¿3 contains all sensors included in cluster S2. 
Differences within the theta band range 
Very similar to previous results, power within the theta 
range was significantly higher in the a-md-MCI group. 
The a-md-MCI group showed increased relative power 
(£=-2.007;/><0.05) as compared with a-sd-MCIs with-
in a 5-7 Hz frequency range in a cluster of sensors 
(cluster 0i) located in left centro-parietal regions (see 
Fig. 5). The a-sd-MCI group showed increased power 
within the typical 4-8 Hz range of theta band in two 
clusters of sensors (clusters 92 and 93) when compared 
a-sd-MCI vs a-md-MCI Control vs a-sd-MCI 
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Fig. 6 Differences within the alpha band range. The cluster in 
blue represents an increase in relative power within the a-sd-MCI 
group in occipital regions (cluster a{), as compared with the a-md-
MCI group. The control group showed more relative power in 
right fronto-temporal areas (cluster a2), in bilateral occipital re-
gions (cluster a3), and in right lateral fronto-temporal regions 
(cluster a4) than both MCI groups. These clusters are represented 
in green color 
a-sd-MCI vs a-md-MCI Control vs a-sd-MCI Control vs a-md-MCI 
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Fig. 7 Differences within the beta band range. Blue color indi-
cates that the a-sd-MCI group exhibited increased relative power 
in a fronto-central cluster (cluster ¡3{) as compared with a-md-
with the control group. Cluster 92 ( ¿=-2 .939 ; Í?<0 .005) 
extended over most of the right lateral fronto-temporo-
parieto-occipital region, while cluster 93 (¿=-2.231; 
p<0.05) had a left fronto-central location. When a-md-
MCIs and controls were compared, the a-md-MCIs 
exhibited the same pattern of increased relative power 
within the 4-8 Hz range (¿=-4.107; /?<0.0001), but in 
this case, such differences emerged from a cluster that 
basically included all sensors excepting those located 
around the vertex (cluster 94). Consequently, cluster 94 
encompassed sensors and frequency ranges in clusters 
9\, 92, and 93 (see below). 
Differences within the alpha band range 
The a-md-MCI group (see Fig. 6) showed reduced 
relative power values as compared to a-sd-MCIs in a 
small occipital cluster of sensors (cluster a{) within a 
frequency range of 9-11 Hz (¿=2.457; p<0.0l). The 
a-sd-MCI group exhibited reduced relative power as 
compared to controls (¿=2.279; p<0.05) within a 10-
12 Hz frequency range in a small right fronto-
temporal cluster of sensors (cluster a2). Finally, a-
md-MCIs showed significantly lower relative power 
values within an 8-12 Hz frequency range in two 
different clusters of sensors. Cluster a3 (¿=2.752; 
/?<0.001) extended bilaterally over the occipital region 
and contained all sensors in cluster o¿\ (see below). 
Cluster a4 (¿=2.703; p<0.001) extended over the right 
lateral fronto-temporal region and contained all sen-
sors in cluster a2. 
MCI. In the control group, there is an increased of relative power, 
indicated in green color, in occipital areas (clusters ¡32 and /33) 
when compared with a-sd and a-md-MCI groups 
Differences within the beta band range 
As previously described for the alpha range, relative 
power within the beta range was significantly decreased 
in the MCI groups (see Fig. 7). Of note, a-md-MCIs 
showed reduced relative power as compared with a-sd-
MCIs (¿=2.262;/><0.05) in a fronto-central cluster with 
left predominance (cluster j3\) within a frequency range 
of 20-22 Hz. The a-sd-MCI group exhibited lower 
power values than controls within a broader frequency 
range of 16-23 Hz (¿=2.654;/><0.001) in a small cluster 
of occipital sensors (cluster j32). Similarly, a-md-MCIs 
showed reduced power values as compared with con-
trols (¿=2.126; p<0.05) in the same 16-23 frequency 
range of 16-23 Hz and basically within the same occip-
ital cluster of sensors observed in the controls vs. a-sd-
MCI comparison (cluster j3j). 
Power, hippocampal volumes, and neuropsychology 
correlations 
As previously described, a series of exploratory one-way 
ANOVAs were performed to assess the differences in 
terms of neuropsychological tests performance and hip-
pocampal volumes among groups. Firstly, the ANOVA 
revealed a significant effect of "Diagnosis" on LHICV 
and RHICV (¿K0.0001) (see Table 1). Post hoc com-
parisons with Bonferroni correction showed significant 
differences for LHICV and RHICV between controls 
and MCIs (/?<0.001), with larger hippocampal volumes 
within the healthy group. On the other hand, a-md-MCIs 
exhibited smaller volumes than a-sd-MCIs, but the 
comparison failed to reach the level of statistical signifi-
cance (p>0.05). A significant effect of "Diagnosis" was 
also found for all neuropsychological tests, with the 
exception of clock drawing test, VOSP, and TMTA ac-
curacy. This initial finding was further explored by means 
of post hoc pair-wise comparison with Bonferroni cor-
rection. MMSE scores were significantly higher in con-
trol subjects as compared with both clinical groups 
(p<0.00l), but in addition, a-sd-MCI's MMSE scores 
were significantly higher as compared to those of a-md-
MCIs (p<0.0l; see Table 1). Direct digit span scores 
were significantly higher in controls, as compared with 
both clinical groups (p<0.05), but no significant differ-
ences emerged from the comparison of MCI subtypes. 
Identical results were obtained in the analysis of inverse 
digit span, and immediate and delayed recall. Phonemic 
fluency scores were also significantly higher in controls 
when compared with both clinical groups (p<0.05), and 
a-sd-MCIs showed significantly increased fluency values 
than a-md-MCIs (p<0.05). Controls also exhibited in-
creased semantic fluency values (p<0.05), but no signif-
icant differences were found between MCI subtypes. An 
identical pattern was found in the comparison of TMTA 
time and TMTB accuracy and time scores. In both cases, 
a-sd-MCI showed higher scores as compared to a-md-
MCIs, but the effect did not reach the significance level. 
Ideomotor Praxis values were also significantly higher in 
controls (p<0.05). Finally, BNT scores presented a slight-
ly different behavior. First, no significant differences 
emerged from the comparison of controls and a-sd-MCI 
patients. However, controls showed higher scores than a-
md-MCIs (p<0.0l), and a-md-MCIs exhibited signifi-
cantly higher scores than a-sd-MCIs (p<0.05). According 
to these results, it seems that both MCI groups are sim-
ilarly impaired in memory performance, but a-md-MCIs 
tend to show a poorer performance in language tasks, 
especially in the BNT. Additionally, a-md-MCIs present-
ed the lowest MMSE scores, indicating a significantly 
more impaired general cognitive status. 
Once this exploratory analysis was carried out, and 
with the aim of investigating the relationship between 
neurophysiological activity, hippocampal atrophy and 
cognitive performance, averaged power values in the 
significant clusters were correlated with hippocampal 
volumes and neuropsychological test scores in the 
whole sample (a-md-MCIs+a-sd-MCIs+controls). In 
order to avoid redundant information, and considering 
the high degree of ovelapping among clusters, we de-
cided to submit for correlation analyses only those 
clusters that matched the following criteria: (1) clusters 
without spatial or spectral coincidence with other clus-
ters (i.e., clusters Si and ¡3\), and (2) broader clusters that 
encompassed the sensors and spectral ranges of smaller 
clusters (i.e., S3, 94, a3, a4, and /33). Pearson's "r" and 
"p" values of all significant correlations are displayed in 
Table 2. Within the delta band range, cluster Si was 
inversely correlated with MMSE, inverse digit span, 
and TMTA accuracy, indicating that higher scores in 
this cluster are associated with a lower cognitive status. 
Cluster Si was positively correlated with TMTA time. 
Cluster ¿3 was inversely correlated with MMSE, inverse 
digit span, immediate and delayed recall, phonemic 
fluency, and TMTB accuracy. Mirroring cluster Si, clus-
ter S3 was also directly correlated with TMTA time. 
Cluster 04 was inversely correlated with both hippo-
campus and several tests: MMSE, inverse digit span, 
immediate recall, delayed recall, rule shift cards, phone-
mic fluency, TMTA and TMTB accuracy, and BNT. On 
the other hand, cluster 64 was directly correlated with 
TMTA and TMTB time. The pattern of correlations 
within the low-frequency domain clearly suggests that 
the higher activity within delta and theta ranges, the 
poorer cognitive performance in several domains. 
Cluster a3 was directly correlated with immediate 
and delayed recall, inverse digit span, and phonemic 
fluency, indicating that higher posterior activity within 
the alpha range is associated with a better cognitive 
performance. Cluster «3 was inversely correlated with 
TMTB time. Supporting this idea, cluster a4 was also 
positively correlated with both hippocampus, MMSE, 
inverse digit span, and immediate and delayed recall. 
Finally, within the beta range, cluster j3i was directly 
correlated with MMSE, BNT, and TMTB accuracy. 
Cluster /33 was positively correlated with both hippo-
campal volumes, immediate and delayed recall. This 
correlation pattern suggests that an enhanced activity 
within the high-frequency range is associated with a 
lesser hippocampal atrophy and a better cognitive 
performance. 
Lastly, in order to explore the relationship between 
hippocampal volumes and neuropsychological scores, 
both measures were correlated. LHICV was positively 
correlated with MMSE (p=0.0040; r=0.3832), imme-
diate recall (p=1.8* 1(T6; r=0.4992), delayed recall 
(/?=6.2xl(r10; r=0.5941), VOSP (p=0.0212; r= 
0.2558), and TMT B (accuracy) (p=0.0430; r= 
0.2328) and negatively with TMT B (time) (p=0.032; 
r=-0.2446). Similarly, RHICV was directly correlated 
Table 2 Pearson correlation analyses of averaged power values in the significant clusters with neuropsychological test scores and 
hippocampal volumes in the whole sample 
Cluster 
MMSE 
Inverse Digit Span 
Immediate Recall 
Delayed Recall 
TMTA(acc) 
TMTA(time) 
TMT B (ace.) 
TMT B (time) 
BNT 
Phonemic Fluency 
LHJCV 
RHJCV 
Si 
P= 
r= 
P= 
r= 
n.s 
n.s 
P= 
P= 
n.s 
n.s 
n.s 
n.s 
n.s 
n.s 
0.01115 
-0.2528 
0.03296 
-0.2114 
0.00417 
-0.2827 
0.03870 
0.2061 
<53 
p=0.01201 
r=-0.25033 
p=0.00078 
r=-0.32741 
p=0.00003 
r=-0.39799 
p=0.00118 
r=-0.32295 
n.s. 
p=0.01142 
r=0.25080 
p=0.02988 
r=-0.22656 
n.s. 
n.s. 
p=0.00078 
r=-0.32889 
n.s. 
n.s. 
a, 
p=0.00032 
r=-0.35269 
p=0.00700 
r=-0.26550 
p=0.000001 
r=-0.45913 
p=0.000001 
r=-0.49822 
p=0.03475 
r=-0.21034 
n.s. 
p=0.00125 
r=-0.33153 
n.s. 
p=0.01214 
r=-0.24996 
p=0.02630 
r=-0.22109 
p=0.0032 
r=-0.3196 
p=0.0022 
r=-0.3309 
« 3 
n.s. 
p=0.02979 
r=0.21526 
p=0.00992 
r=0.25424 
p=0.01768 
r=0.23922 
n.s. 
n.s. 
n.s. 
p=0.01086 
r=-0.26303 
n.s. 
p=0.02740 
r=0.21953 
n.s. 
n.s. 
" j 
p=0.00125 
r=0.31824 
p=0.02038 
r=0.22940 
p=0.00041 
r=0.34337 
p=0.00037 
r=0.35267 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
p=0.0022 
r=0.2501 
p=0.0533 
r=0.2129 
Pi 
p=0.03455 
r=0.21162 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
p=0.01580 
r=0.25102 
n.s. 
p=0.04702 
r=0.19912 
n.s. 
n.s. 
n.s. 
& 
n.s. 
n.s. 
p=0.00331 
r=0.28818 
p=0.00083 
r=0.33234 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
p=0.0235 
r=0.2485 
p=0.0003 
r=0.3882 
The table shows the "p" and "r" (correlation index) values that were significant (p<0.05) 
with MMSE (p=0.0018; r=0.3413), immediate recall 
(/?=0.8xl(T5, r=0.4709); delayed recall (p=3.93x 
1(T7; r=0.5314), rule shift cards (p=0.0422; r= 
0.2292), TMT B (accuracy) (p=0.0164; r=0.2745), 
and inversely correlated with TMT B (time) (p-
0.0064; r=—0.3081). These findings confirm the rela-
tionship among the hippocampal atrophy, the neuro-
physiological changes, and the global deficit observed 
in different cognitive domains, such as memory, percep-
tion, or executive functioning. 
Discussion 
We are aware that the clusterization of the frequency 
bands done in this study rendered difficult the compar-
ison of our findings with the previously published liter-
ature. For this reason, we decided to compare the current 
findings with the classical frequency band closer to the 
frequency cluster found in this study. 
The results of the present study basically support 
previous reports about EEG/MEG spectral analysis in 
MCI and add new information on the spectral profiles of 
MCI subtypes that was not previously addressed. As it 
might be expected, MCI patients (especially the a-md-
MCI group) showed a generalized power increase with-
in the theta range accompanied by a power decrease 
within the alpha and beta ranges in the posterior regions 
of the brain. More importantly, a-md-MCIs exhibited 
increased power within the delta and theta ranges as 
compared with a-sd-MCIs. This tendency (see Fig. 2) 
is a new example of the "shift to the left" in the spectral 
profile observed in AD and MCI patients that correlates 
with the degree of cognitive impairment (Fernandez 
et al. 2006b; Rodriguez et al. 1999). 
From the last years, there is evidence of hyperactiva-
tion (Dickerson et al. 2005; Maestu et al. 2008) or 
hypersynchronization (Bajo et al. 2010) of different 
regions of the brain in patients with amnestic MCI in 
comparison to healthy controls but as well to AD pa-
tients. This increase is an indication of compensatory 
activity due to the loss of efficiency of the memory 
networks that leads to the idea of a nonclear linear 
neurophysiological process between healthy aging and 
dementia. In addition, there are some biochemical 
(Lavenex and Amaral 2000) or resting state functional 
studies (Osipova et al. 2006) that suggest that the differ-
ences between controls and MCI patients seem not to be 
so linear as our present results. Nonetheless, overall our 
findings seem to confirm the hypothesis of a spectral 
pattern more proximate to the typical AD profile, mainly 
in a-md-MCIs. Previous EEG (Babiloni et al. 2004; 
Dauwels et al. 2011; Huang et al. 2000; Jeong 2004) 
and MEG studies (Berendse et al. 2000; Fernandez et al. 
2002, 2003, 2006b) of AD found an increased power in 
the low-frequency bands (delta and theta), accompanied 
by a decreased power in the high-frequency range (al-
pha, beta, and gamma). Such pattern of spectral changes 
is a consistent finding that correlates with cognitive 
performance and functional status (Fernandez et al. 
2002; Prichep et al. 1994; van Deursen et al. 2008). 
More specifically, in a previous study of our group 
(Fernandez et al. 2006a), AD patients were character-
ized by a power increase within the 2^1-Hz frequency 
range, accompanied by a power decrease within the 16-
28 Hz frequency range that basically parallels the spec-
tral changes observed in the present investigation of 
MCI patients. 
The sequence of spectral changes in AD is assumed 
to start with an increase in theta and a decrease in beta 
activity, which are followed by a decrease in alpha 
activity. Delta power is usually believed to increase only 
in more severe stages of the disease (Jeong 2004). 
However, several studies also reported an increase in 
delta power in MCI patients when compared with 
healthy aged controls (see, for example, Babiloni et al. 
2006a, b, 2010; Rossini et al. 2008). Moreover, 
Fernandez et al. (2006c) demonstrated than MCI pa-
tients with elevated delta activity in posterior parietal 
regions had a significantly elevated risk of conversion to 
AD. This line of evidence indicates that very similar 
patterns of neurophysiological activity can be found in 
MCI patients and AD patients, supporting the idea of 
some degree of overlapping (Fernandez et al. 2006b). 
An increase in low-frequency activity is not the only 
shared characteristic. MCI and AD share neuropatho-
logical and functional features, including: tau and ApoE 
abnormal proteins (Mufson et al. 1999), reduced hippo-
campal and temporal lobe volumes (Jack et al. 1999; 
Martin et al. 2010), temporo-parieto-occipital 
hypometabolism-hypoperfusion in PET or SPECT 
scans (Nestor et al. ), and cholinergic dysfunction 
(Haenseetal. 2012). 
The "proximity" of a-md-MCIs' spectral profiles to 
the typical AD pattern, together with the significantly 
lower MMSE, phonemic fluency, and language scores 
within this group (see Table 1), may be interpreted as a 
sign of greater deterioration in these patients. This affir-
mation is supported by the correlations between neuro-
physiological, structural, and neuropsychological data. 
The a-md-MCI group showed the highest levels of 
activity within delta and theta ranges, and such activity 
was inversely correlated with MMSE scores and hippo-
campal volumes (in this case, only theta range power). 
In addition, activity within delta and theta ranges was 
inversely correlated with the performance on tests of 
memory, language, attention, and executive functions 
such as immediate and delayed recall, inverse digit span, 
TMTA and TMTB, BNT, etc. The correlation pattern of 
clusters within alpha and beta ranges was also illustra-
tive. The a-md-MCI group exhibited the lowest power 
within the alpha and beta ranges, especially in posterior 
sites, compared with the control group. Relative power 
values within the alpha range were directly correlated 
with hippocampal volumes and scores of immediate and 
delayed recall, inverse digit span, etc. Similarly, an 
increased activity within the beta range was positively 
correlated not only with hippocampal volumes and 
global cognitive status (i.e., MMSE) but also with the 
performance on tests of memory, language, and execu-
tive functioning. Overall, a-md-MCIs exhibited the 
highest power values in the low-frequency range, the 
lowest power values in the high-frequency range, the 
poorer cognitive performance, and the smaller hippo-
campal volumes. 
The correlation between spectral profiles and cogni-
tive performance was previously assessed in several 
studies. For example, in their classic study, Jelic et al. 
(1996) reported negative correlations between relative 
theta power, visuospatial function, memory and atten-
tion. More recent investigations showed very similar 
tendencies. Van der Hiele et al. (2007) found negative 
correlations between theta power and tests of global 
domain. In addition, negative correlations with tests 
such as the TMTB or semantic fluency were described 
by the authors. Babiloni et al. (2010) described negative 
correlations between delta power, Stroop and digit-
symbol tests, while alpha 1 power was directly correlat-
ed with these neuropsychological measures. Although 
these investigations assessed the correlation between 
spectral and neuropsychological data, the importance 
of the regional distribution was not explicitly explored. 
It is noteworthy that the most significant difference 
between a-md-MCIs (i.e., patients with the poorest cog-
nitive performance and lowest mental status) and a-sd-
MCI patients appeared in fronto-central region (cluster 
Si). The implication of more anterior sites is associated 
with a posterior-to-anterior tendency of neurophysiolog-
ical abnormalities, such as focal delta activity, observed 
with the progress of the disease (Fouquet et al. 2009; 
Osipova et al. 2005). 
As in some previous studies (Whitwell et al. 2007; 
He et al. 2009; Zhang et al. 2012), where a-MCI sub-
types were compared, we failed to find significant sta-
tistical differences in hippocampal volumes. However, 
in a follow-up study, Tabert et al. (2006) found that 38 
out of 39 patients that converted to AD had a baseline 
diagnosis of a-md-MCI, while none of them had a 
baseline diagnosis of a-sd-MCI. Diniz et al. (2009) 
found that those MCI who progress to dementia showed 
a worse global cognitive performance and multiple cog-
nitive deficits at baseline than those MCI who remained 
stable. Similarly, Han et al. (2012) reported that the rate 
of progression to dementia in a-sd-MCI patients was 
very similar to the rate of reversion to the normal cog-
nition, while in the a-md-MCI group, the rate of con-
version to dementia was significantly higher when com-
pared to the rate of reversion. Interestingly, the authors 
interpreted these findings as a sign of broader cerebral 
"degeneration" in the a-md-MCI group. The findings of 
Brodaty et al. (2012) mirrored those reported by Han 
and coworkers. 
The relationship between elevated risk of conversion 
and presence of neuropathological signs has been 
established in a-md-MCI patients. For instance, Caffarra 
et al. (2008) accomplished a follow-up study where a-
sd-MCI, a-md-MCIs, and "dysexecutive MCI" patients 
underwent SPECT evaluation at baseline. Both amnestic 
groups showed significant hypoperfusion in the left 
hippocampus and parahippocampal gyrus, but a-md-
MCIs showed an additional hypoperfusion in left pos-
terior cingulated gyrus. Notably, the 55 % of a-md-
MCIs progressed to AD in a maximum follow-up period 
of 24 months, while none of the a-sd-MCI patients 
progressed to dementia. These results might suggest 
that, contrary to the classical understanding of a-MCI 
as a risk factor for dementia, the a-sd-MCI subtype is in 
fact a "benign" form of MCI. This challenging idea was 
posed by Nordlund et al. (2010) in an excellent investi-
gation. The authors evaluated the 2-year outcome in a 
sample composed of a-sd-MCIs, a-md-MCIs, na-sd-
MCIs, and na-md-MCIs. In addition, cerebrospinal fluid 
(CSF) samples were collected to estimate tau levels at 
baseline. Paralleling previous studies, only multidomain 
cases progressed to dementia, but more specifically 18 
out of 21 patients that progressed to dementia had a 
baseline diagnosis of a-md-MCI. In fact, elevated tau 
levels in CSF and a diagnosis of a-md-MCI were the 
best predictors of progression to dementia. The results 
of Norlund et al. further confirm the findings of Wolk 
et al. (2009) of elevated levels of AD pathology in a-md-
MCIs, in this case represented by a significantly higher 
number of Pittsburgh Compound B-positive cases that 
exhibited an increased risk of conversion to AD. 
At this point, three lines of evidence converge: (1) a-
md-MCI and AD biological markers seem to overlap in 
a significant percentage of cases; (2) several studies 
support the notion of a more severe brain deterioration 
with a more frequent presence of AD-pathology and an 
elevated risk of conversion to AD in a-md-MCI subtype; 
and (3) our results indicate that a-md-MCIs exhibit a 
spectral profile very similar to that observed in AD, 
which is associated with a more severe cognitive dete-
rioration. Taken together, these lines of evidence lead us 
to discuss the notion of a-md-MCI as an independent 
clinical condition. Recently, in a key position article, 
Dubois et al. (2010) revised the definition of AD and 
some related disorders. According to the new perspec-
tive proposed by the authors, some patients previously 
described as having MCI should be actually considered 
as suffering from "prodromal" AD. This is to say that 
they already have AD. The category of prodromal AD 
encompasses all patients previously considered as hav-
ing MCI who show positive biomarker evidence of AD 
pathology in their brains. The concept of MCI only 
remains to define those patients that do not show bio-
marker evidence of AD pathology. 
According to previous literature and our own results, 
a-md-MCIs might be more likely to fulfill the criteria of 
prodromal AD proposed by Dubois et al. (2010). Nev-
ertheless, the more important question addressed by our 
investigation is the potential role of neurophysio logical 
techniques (EEG or MEG) as markers for AD patholo-
gy. In a very recent study of our group (Fernandez et al. 
2013), it was demonstrated that delta current densities in 
posterior parietal, occipital, prerolandic, and precuneus 
cortices distinguished among MCI patients, AD patients 
with different severity scores, and controls. More im-
portantly, an increase in delta activity in posterior re-
gions such as the right posterior parietal cortex and the 
precuneus indexed the transition from MCI to mild and 
from mild to more severe dementia. Considering the 
close relationship between cholinergic inputs and neu-
rophysiological activity, we proposed that MEG spectral 
mapping might be a serious candidate for a "neural 
degeneration" marker of AD reflecting dysfunctional 
synaptic transmission. The new results presented here 
might support the role of MEG spectral analysis in the 
investigation within the healthy aging-AD continuum, 
particularly as an objective marker of disease progres-
sion associated with cognitive deterioration. Notwith-
standing, the confirmation of such role should be 
attained by correlating MEG spectral data with CSF or 
imaging markers of AD. In addition, the spectral infor-
mation should be evaluated in individuals with elevated 
risk of developing AD such as the APOE4 carriers. 
According to our results, we hypothesize that patients 
with a diagnosis of a-md-MCI showing an exaggerated 
activity within the delta and theta ranges are cases of 
prodromal AD (according to the definition of Dubois 
et al.) with an elevated risk of rapid progression to a 
fully declared dementia. If this strong hypothesis is 
confirmed, MEG spectral analysis might serve as a 
quantitative measure to define the neurophysiological 
characteristics of prodromal AD. 
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